Charity Navigator bestows MMRF coveted 4-star rating for efforts in finding cure for multiple myeloma

NewsGuard 100/100 Score

The Multiple Myeloma Research Foundation (MMRF) announced today that it has received a 4-star rating from Charity Navigator, America's largest independent evaluator of charitable donations, for demonstrating exceptional fiscal responsibility in its efforts to bring patients the next generation of treatments and find a cure for multiple myeloma. This is the seventh consecutive year the MMRF has been honored with this distinguished recognition.

“this exceptional designation differentiates the MMRF from its peers and demonstrates to the public it is worthy of their trust.”

The coveted 4-star rating, the highest honor Charity Navigator bestows, has been awarded to only two percent of charities. According to Charity Navigator, “this exceptional designation differentiates the MMRF from its peers and demonstrates to the public it is worthy of their trust.”

"Charity Navigator’s 4-star rating underscores our tireless commitment to accountability and measurable results” said Kathy Giusti, Founder and CEO of the MMRF. “Running lean and being efficient is an essential part of our culture. In today’s uncertain economy, it is more important to us than ever that our donors are certain we maximize every dollar they invest.”

In addition to receiving the 4-star rating from Charity Navigator, the MMRF has received A "Best in America" Seal of Excellence from the Independent Charities of America, an A+ from the American Institute of Philanthropy, and is in compliance with all of the Better Business Bureau's (BBB) Wise Giving Alliance Standards for Charity Accountability. The MMRF has also received approval from the National Cancer Institute for its research grants program.

SOURCE Multiple Myeloma Research Foundation (MMRF)

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Microplastics detected in all human placenta samples